CDER Pilot Program Offers Potential New Pathway For Approval Of Novel Pharmaceutical Excipients
After decades without an approval pathway for excipients, FDA pilot program paves the way for innovation.
After decades without an approval pathway for excipients, FDA pilot program paves the way for innovation.